Shares of ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) traded down 7.4% during trading on Tuesday . The company traded as low as $0.39 and last traded at $0.41. 213,862 shares were traded during mid-day trading, an increase of 952% from the average session volume of 20,327 shares. The stock had previously closed at $0.44.
ImmunoPrecise Antibodies Price Performance
The stock has a 50 day moving average of $0.55 and a 200 day moving average of $0.81.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- EV Stocks and How to Profit from Them
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- How to Capture the Benefits of Dividend Increases
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
